Capital Goods Healthcare Sector

Alterola Biotech

Market Cap: US$1.5m

A pharmaceutical company, engages in the development of medicines manufactured from cannabinoid and cannabinoid-like molecules.

RespireRx Pharmaceuticals

Market Cap: US$1.4m

Engages in the discovery, development, and commercialization of pharmaceuticals for the treatment of neurological and psychiatric disorders.

Bio-Path Holdings

Market Cap: US$1.4m

Operates as a clinical and preclinical stage oncology focused RNAi nanoparticle drug development company in the United States.

InVitro International

Market Cap: US$1.4m

Develops test kits for non-animal testing applications in the United States and internationally.

SOHM

Market Cap: US$1.4m

Develops, manufactures, markets, and distributes generic and private label pharmaceutical products in the United States.

CardioComm Solutions

Market Cap: CA$1.9m

Develops advanced software and hardware products, and core laboratory reading services related to electrocardiogram (ECG) and ambulatory arrhythmia monitoring systems for medical and consumer markets worldwide.

iCoreConnect

Market Cap: US$1.4m

A cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States.

Therapeutic Solutions International

Market Cap: US$1.4m

Therapeutic Solutions International, Inc.

Hexima

Market Cap: AU$2.2m

Does not have significant operations.

Halberd

Market Cap: US$1.3m

A biotech company, develops treatments for neurodegenerative diseases.

Acura Pharmaceuticals

Market Cap: US$1.3m

An innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States.

Appili Therapeutics

Market Cap: CA$1.8m

A biopharmaceutical company, focuses on the acquisition and development of novel medicines for unmet needs in infectious disease in Canada.

Dakshidin Corporation

Market Cap: US$1.3m

Through its subsidiaries, operates as a CBD/cannabis-based medical product company.

Allied

Market Cap: US$1.3m

A cannabis company, develops, manufactures, and markets hemp derived cannabis products in the United States.

American Green

Market Cap: US$1.3m

Operates as a technology company in the medical cannabis industry in the United States.

Medical Care Technologies

Market Cap: US$1.3m

A development stage company, engages in opening and operating children’s integrated health and wellness centers in China.

Bespoke Extracts

Market Cap: US$1.3m

Bespoke Extracts, Inc., along with its subsidiary, Bespoke Extracts Colorado, LLC, specializes in the production and sale of pre-rolled marijuana cigarettes in the United States.

AdAlta

Market Cap: AU$1.9m

A clinical stage biotechnology company, discovers and develops protein and cell-based therapeutics by its i-body platform in Australia.

Certive Solutions

Market Cap: CA$1.8m

Provides revenue cycle consultative services and solutions in the United States.

Modern Mobility Aids

Market Cap: US$1.2m

Operates in the telehealth and telemedicine industry.

Shortwave Life Sciences

Market Cap: UK£871.8k

Through its subsidiary, Blossom Analysis, provides a data and insights platform for the psychedelic healthcare industry.

Panbela Therapeutics

Market Cap: US$1.2m

A clinical-stage biopharmaceutical company, engages in the development of disruptive therapeutics for the treatment of patients with urgent unmet medical needs.

Avenir Wellness Solutions

Market Cap: US$1.2m

Through its subsidiary The Sera Labs, Inc., engages in the development of nutraceutical formulation and delivery technologies in novel dosage forms to improve efficacy and enhance wellness.

Odyssey Health

Market Cap: US$1.2m

A medical company, focuses on the development and acquisition of medical related products.

Target Group

Market Cap: US$1.2m

Target Group Inc. cultivates, processes, and distributes curated cannabis products for the medical and adult-use recreational cannabis market in Canada and the United States.

Procaps Group

Market Cap: US$1.1m

Develops, produces, and markets pharmaceutical solutions worldwide.

Silo Wellness

Market Cap: CA$1.5m

A psychedelics and wellness company, develops psychedelic medicine to reduce trauma.

Shuttle Pharmaceuticals Holdings

Market Cap: US$1.1m

A clinical stage pharmaceutical company, develops novel therapies to cure cancers.

Access-Power

Market Cap: US$1.1m

A medical marijuana clone company, manufactures and distributes medical marijuana clone products.

PreAxia Health Care Payment Systems

Market Cap: US$1.1m

Engages in the development, distribution, marketing, and sale of health care payment processing services and products.

Captor Capital

Market Cap: CA$1.5m

Engages in the retail sale of cannabis products in the United States.

SCWorx

Market Cap: US$1.1m

Engages in the provision of data content and services related to the repair, normalization and interoperability of information for healthcare providers in the United States.

Ocean Biomedical

Market Cap: US$1.1m

A biopharmaceutical company, focuses on discovering and developing therapeutic products in oncology, fibrosis, and infectious diseases in the United States.

Entheon Biomedical

Market Cap: CA$1.5m

Operates as a biotechnology research and development company.

Aibotics

Market Cap: US$1.1m

Engages in the study of psychedelics for the treatment of mental health issues in the United States.

SPO Global

Market Cap: US$1.1m

Does not have significant operations.